Total Payments
$4,910
2024 Payments
$1,598
Companies
27
Transactions
131
Medicare Patients
8,795
Medicare Billing
$979,999
Payment Breakdown by Category
Food & Beverage$2,755 (56.1%)
Travel$1,028 (20.9%)
Other$870.00 (17.7%)
Education$168.12 (3.4%)
Consulting$90.00 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,755 | 120 | 56.1% |
| Travel and Lodging | $1,028 | 5 | 20.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $870.00 | 1 | 17.7% |
| Education | $168.12 | 4 | 3.4% |
| Consulting Fee | $90.00 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca UK Limited | $1,368 | 10 | $0 (2018) |
| GlaxoSmithKline, LLC. | $929.37 | 48 | $0 (2024) |
| Mylan Specialty L.P. | $870.00 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $472.61 | 19 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $263.88 | 9 | $0 (2024) |
| Pulmonx Corporation | $110.23 | 1 | $0 (2022) |
| Inari Medical, Inc. | $91.54 | 1 | $0 (2024) |
| Grifols USA, LLC | $90.16 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $89.52 | 4 | $0 (2024) |
| Insmed, Inc. | $84.44 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,598 | 83 | GlaxoSmithKline, LLC. ($639.95) |
| 2023 | $210.35 | 11 | Regeneron Healthcare Solutions, Inc. ($36.77) |
| 2022 | $536.11 | 14 | GlaxoSmithKline, LLC. ($260.12) |
| 2021 | $11.58 | 1 | AstraZeneca Pharmaceuticals LP ($11.58) |
| 2020 | $883.53 | 2 | Mylan Specialty L.P. ($870.00) |
| 2019 | $28.54 | 2 | GlaxoSmithKline, LLC. ($14.49) |
| 2018 | $1,414 | 13 | AstraZeneca UK Limited ($1,368) |
| 2017 | $228.92 | 5 | AstraZeneca Pharmaceuticals LP ($128.04) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 2 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.11 | General |
| Category: Narcoplepsy | ||||||
| 08/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardio-pulmonary | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.76 | General |
| Category: Narcoplepsy | ||||||
| 07/23/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Immunology | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 07/03/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Neurology | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: RESPIRATORY | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.37 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,040 | 2,604 | $711,591 | $245,820 |
| 2022 | 19 | 2,381 | 2,886 | $730,865 | $248,385 |
| 2021 | 15 | 2,327 | 2,995 | $776,404 | $267,599 |
| 2020 | 19 | 2,047 | 2,695 | $611,690 | $218,195 |
Total Patients
8,795
Total Services
11,180
Medicare Billing
$979,999
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 487 | 769 | $218,396 | $81,671 | 37.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 73 | 188 | $112,048 | $34,064 | 30.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 130 | 206 | $49,270 | $20,745 | 42.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 103 | 103 | $44,290 | $15,078 | 34.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 79 | 101 | $39,895 | $14,859 | 37.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 48 | 48 | $31,776 | $13,492 | 42.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 128 | 188 | $30,726 | $12,441 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 121 | $24,200 | $8,714 | 36.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 170 | 171 | $31,479 | $8,392 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $20,805 | $7,915 | 38.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $13,041 | $4,936 | 37.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 124 | 124 | $17,875 | $4,735 | 26.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 95 | 95 | $19,000 | $3,180 | 16.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 107 | 107 | $11,770 | $2,981 | 25.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 45 | 45 | $8,100 | $2,114 | 26.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 21 | 21 | $8,190 | $1,943 | 23.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 53 | 53 | $8,480 | $1,867 | 22.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 73 | 74 | $8,787 | $1,743 | 19.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $4,656 | $1,673 | 35.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 48 | 48 | $2,160 | $1,578 | 73.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 14 | 14 | $5,670 | $1,452 | 25.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 15 | 15 | $600.00 | $150.90 | 25.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 13 | 13 | $377.00 | $97.24 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 456 | 684 | $194,256 | $71,663 | 36.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 66 | 146 | $87,016 | $26,990 | 31.0% |
About Dr. Eric Sztejman, MD
Dr. Eric Sztejman, MD is a Pulmonary Disease healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255386355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Sztejman, MD has received a total of $4,910 in payments from pharmaceutical and medical device companies, with $1,598 received in 2024. These payments were reported across 131 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,755).
As a Medicare-enrolled provider, Sztejman has provided services to 8,795 Medicare beneficiaries, totaling 11,180 services with total Medicare billing of $979,999. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Marlton, NJ
- Active Since 05/24/2006
- Last Updated 12/12/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1255386355
Products in Payments
- FASENRA (Drug) $1,368
- Yupelri (Drug) $870.00
- NUCALA (Biological) $542.22
- TEZSPIRE (Biological) $171.92
- AREXVY (Drug) $155.96
- Wakix (Drug) $140.09
- DUPIXENT (Biological) $137.60
- WAKIX (Drug) $123.79
- TRELEGY ELLIPTA (Drug) $111.69
- CHARTIS CATHETER (Device) $110.23
- FLOWTRIEVER CATHETER, S (Device) $91.54
- Prolastin-C Liquid (Biological) $90.16
- FASENRA (Biological) $89.85
- Arikayce (Drug) $84.44
- ClearSight System (Device) $82.48
- XYWAV (Drug) $65.02
- Xolair (Biological) $63.68
- AIRSUPRA (Drug) $54.05
- BREZTRI (Drug) $53.86
- OFEV (Drug) $36.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Marlton
Dr. Mark Weir, Mb Chb, MB CHB
Pulmonary Disease — Payments: $7,553
Pulmonary Disease $7,553
Dr. Emilio Mazza, Md, MD
Pulmonary Disease — Payments: $4,892
Pulmonary Disease $4,892
Allen Salm, Md, MD
Pulmonary Disease — Payments: $4,688
Pulmonary Disease $4,688
Abhishek Agarwal, Md, MD
Pulmonary Disease — Payments: $4,388
Pulmonary Disease $4,388
Matthew Gordon, Md, MD
Pulmonary Disease — Payments: $4,385
Pulmonary Disease $4,385
Dr. Jonathan Galli, M.d, M.D
Pulmonary Disease — Payments: $3,450
Pulmonary Disease $3,450